{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:27:50Z","timestamp":1792758470436,"version":"4.5.0"},"reference-count":285,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl J Gynecology &amp;amp; Obste"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In 2014, FIGO's Committee for Gynecologic Oncology revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high\u2010grade serous carcinomas (HGSCs). Stage IC is now divided into three categories: IC1 (surgical spill), IC2 (capsule ruptured before surgery or tumor on ovarian or fallopian tube surface), and IC3 (malignant cells in the ascites or peritoneal washings). The updated staging includes a revision of Stage IIIC based on spread to the retroperitoneal lymph nodes alone without intraperitoneal dissemination. This category is now subdivided into IIIA1(i) (metastasis \u226410\u2009mm in greatest dimension) and IIIA1(ii) (metastasis &gt;10\u2009mm in greatest dimension). Stage IIIA2 is now \u201cmicroscopic extrapelvic peritoneal involvement with or without positive retroperitoneal lymph node\u201d metastasis. This review summarizes the genetics, surgical management, chemotherapy, and targeted therapies for epithelial cancers, including the treatment of ovarian germ cell and stromal malignancies.<\/jats:p>","DOI":"10.1002\/ijgo.70282","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T06:45:28Z","timestamp":1757054728000},"page":"6-35","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cancer of the ovary, fallopian tube, and peritoneum: 2025\u00a0update"],"prefix":"10.1002","volume":"171","author":[{"given":"Malte","family":"Renz","sequence":"first","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Friedlander","sequence":"additional","affiliation":[{"name":"Royal Hospital for Women  Sydney New South Wales Australia"},{"name":"Prince of Wales Clinical School University of New South Wales  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Berek","sequence":"additional","affiliation":[{"name":"Stanford Women's Cancer Center, Stanford Cancer Institute Stanford University School of Medicine  Stanford California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"e_1_2_19_2_1","volume-title":"Berek and Hacker's Gynecologic Oncology","author":"Berek JS","year":"2021"},{"key":"e_1_2_19_3_1","first-page":"1","volume-title":"Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Atlas of Tumor Pathology","author":"Scully RE","year":"1998"},{"key":"e_1_2_19_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213335.40358.47"},{"key":"e_1_2_19_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.2622"},{"issue":"2","key":"e_1_2_19_6_1","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman RJ","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"e_1_2_19_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0b013e328011a21f"},{"key":"e_1_2_19_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4814"},{"key":"e_1_2_19_9_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6095"},{"key":"e_1_2_19_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1107"},{"key":"e_1_2_19_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00326-6"},{"key":"e_1_2_19_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.11.033"},{"key":"e_1_2_19_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-024-03821-9"},{"key":"e_1_2_19_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2004.09.017"},{"key":"e_1_2_19_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001115)89:10<2076::AID-CNCR7>3.0.CO;2-V"},{"key":"e_1_2_19_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(91)90099-Q"},{"key":"e_1_2_19_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.027946"},{"key":"e_1_2_19_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000368"},{"key":"e_1_2_19_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081467"},{"key":"e_1_2_19_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2005.00572.x"},{"key":"e_1_2_19_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2005.00391.x"},{"key":"e_1_2_19_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70333-3"},{"key":"e_1_2_19_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000353"},{"key":"e_1_2_19_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181bf8111"},{"key":"e_1_2_19_25_1","unstructured":"KurmanRJ CarcangiuML HerringtonCS YoungRH.WHO Classification of Tumours of Female Reproductive Organs.2014."},{"key":"e_1_2_19_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26618"},{"key":"e_1_2_19_27_1","volume-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"Kurman RJ","year":"2014"},{"key":"e_1_2_19_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200011000-00001"},{"key":"e_1_2_19_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.77"},{"key":"e_1_2_19_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18819-5"},{"key":"e_1_2_19_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12113"},{"key":"e_1_2_19_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00187-y"},{"key":"e_1_2_19_33_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388"},{"key":"e_1_2_19_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.183"},{"key":"e_1_2_19_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.215"},{"key":"e_1_2_19_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.119"},{"key":"e_1_2_19_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181a24354"},{"key":"e_1_2_19_38_1","unstructured":"(NCI) NCI.Cancer Stat Facts: Ovarian Cancer 2023.https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html"},{"key":"e_1_2_19_39_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"e_1_2_19_40_1","unstructured":"Society AC.Cancer Facts & Figures\u00a02023.2023https:\/\/www.cancer.org\/cancer\/types\/ovarian\u2010cancer\/about\/key\u2010statistics.html#:~:text=Ovarian%20cancer%20ranks%20fifth%20in is%20about%201%20in%20108"},{"key":"e_1_2_19_41_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"issue":"10","key":"e_1_2_19_42_1","first-page":"534","article-title":"Pattern of gynaecological cancers in Ghana","volume":"77","author":"Nkyekyer K","year":"2000","journal-title":"East Afr Med J"},{"key":"e_1_2_19_43_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2016.1068"},{"key":"e_1_2_19_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910490111"},{"key":"e_1_2_19_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910490110"},{"issue":"2","key":"e_1_2_19_46_1","first-page":"573","article-title":"Hereditary ovarian cancer. Heterogeneity in age at onset","volume":"71","author":"Lynch HT","year":"1993","journal-title":"Cancer"},{"key":"e_1_2_19_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705153362001"},{"key":"e_1_2_19_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj465"},{"key":"e_1_2_19_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.6905"},{"key":"e_1_2_19_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000180854.28831.77"},{"key":"e_1_2_19_51_1","volume-title":"GeneReviews\u00ae","author":"Petrucelli N","year":"1993"},{"key":"e_1_2_19_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.5495"},{"key":"e_1_2_19_53_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1115052108"},{"key":"e_1_2_19_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2017.11.007"},{"key":"e_1_2_19_55_1","volume-title":"SGO Clinical Practice Statement: Genetic Testing for Ovarian Cancer","author":"SGO","year":"2014"},{"key":"e_1_2_19_56_1","unstructured":"Network NCC.Genetic\/Familial High\u2010Risk Assessment: Breast Ovarian Pancreatic and Prostate 2025.https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bopp.pdf"},{"key":"e_1_2_19_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1237"},{"key":"e_1_2_19_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00325"},{"key":"e_1_2_19_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33326-3"},{"key":"e_1_2_19_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.06.033"},{"key":"e_1_2_19_61_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-021-02276-5"},{"key":"e_1_2_19_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-023-01746-4"},{"key":"e_1_2_19_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2024-005449"},{"key":"e_1_2_19_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004563"},{"key":"e_1_2_19_65_1","unstructured":"BathlaN JonesA ReidF.The world ovarian cancer coalition atlas: World Ovarian Cancer Coalition; 2018 [Global trends in incidence mortality and survival].2018https:\/\/worldovariancancercoalition.org\/wp\u2010content\/uploads\/2018\/10\/THE\u2010WORLD\u2010OVARIAN\u2010CANCER\u2010COALITION\u2010ATLAS\u20102018.pdf"},{"key":"e_1_2_19_66_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.766"},{"key":"e_1_2_19_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01224-6"},{"key":"e_1_2_19_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603725"},{"key":"e_1_2_19_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2007.01499.x"},{"key":"e_1_2_19_70_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.21926"},{"key":"e_1_2_19_71_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.200"},{"key":"e_1_2_19_72_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.9330"},{"key":"e_1_2_19_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00335-2"},{"key":"e_1_2_19_74_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00141"},{"key":"e_1_2_19_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003164"},{"key":"e_1_2_19_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.2.113"},{"key":"e_1_2_19_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb12062.x"},{"issue":"1","key":"e_1_2_19_78_1","first-page":"34","article-title":"The role of adjuvant therapy in the management of node negative breast cancer","volume":"83","author":"Young V","year":"1990","journal-title":"Ir Med J"},{"key":"e_1_2_19_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.06.013"},{"key":"e_1_2_19_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.2164"},{"key":"e_1_2_19_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb02448.x"},{"key":"e_1_2_19_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31821b5118"},{"key":"e_1_2_19_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.08.031"},{"key":"e_1_2_19_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.03.043"},{"key":"e_1_2_19_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.03.003"},{"issue":"11","key":"e_1_2_19_86_1","first-page":"A4331","article-title":"Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis","volume":"58","author":"Sorensen SS","year":"2011","journal-title":"Dan Med Bull"},{"issue":"4","key":"e_1_2_19_87_1","first-page":"413","article-title":"Primary cytoreductive surgery for epithelial ovarian cancer","volume":"61","author":"Hacker NF","year":"1983","journal-title":"Obstet Gynecol"},{"key":"e_1_2_19_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.5.1248"},{"key":"e_1_2_19_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.11.018"},{"key":"e_1_2_19_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2008.01190.x"},{"key":"e_1_2_19_91_1","article-title":"Laparoscopy versus laparotomy for FIGO stage I ovarian cancer","volume":"10","author":"Falcetta FS","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_19_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2008.04.002"},{"key":"e_1_2_19_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.04.018"},{"key":"e_1_2_19_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.05.007"},{"key":"e_1_2_19_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.04.013"},{"key":"e_1_2_19_96_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003655"},{"key":"e_1_2_19_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2017.02.013"},{"key":"e_1_2_19_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.08.030"},{"key":"e_1_2_19_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2016.11.004"},{"key":"e_1_2_19_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2016.09.018"},{"key":"e_1_2_19_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00303.x"},{"key":"e_1_2_19_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00262-6"},{"key":"e_1_2_19_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa052"},{"key":"e_1_2_19_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(92)90100-W"},{"key":"e_1_2_19_105_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808424"},{"key":"e_1_2_19_106_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908806"},{"key":"e_1_2_19_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62223-6"},{"key":"e_1_2_19_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30566-7"},{"key":"e_1_2_19_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2015.02.008"},{"key":"e_1_2_19_110_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503093321002"},{"key":"e_1_2_19_111_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.5212"},{"key":"e_1_2_19_112_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000945"},{"key":"e_1_2_19_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.01.017"},{"key":"e_1_2_19_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.10.073"},{"key":"e_1_2_19_115_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004123221501"},{"key":"e_1_2_19_116_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02016"},{"key":"e_1_2_19_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.710"},{"issue":"5","key":"e_1_2_19_118_1","first-page":"40","article-title":"Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III\/IV ovarian cancer (from the gynecologic oncology group)","volume":"23","author":"McGuire WP","year":"1996","journal-title":"Semin Oncol"},{"key":"e_1_2_19_119_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.7.2069"},{"key":"e_1_2_19_120_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6012"},{"key":"e_1_2_19_121_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.153"},{"key":"e_1_2_19_122_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.1684"},{"key":"e_1_2_19_123_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh323"},{"key":"e_1_2_19_124_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.8566"},{"key":"e_1_2_19_125_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612263352603"},{"key":"e_1_2_19_126_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.4.1001"},{"key":"e_1_2_19_127_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052985"},{"key":"e_1_2_19_128_1","article-title":"Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer","volume":"1","author":"Jaaback K","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_19_129_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01568"},{"key":"e_1_2_19_130_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200225"},{"key":"e_1_2_19_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61157-0"},{"key":"e_1_2_19_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70363-2"},{"key":"e_1_2_19_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70049-X"},{"key":"e_1_2_19_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32259-7"},{"key":"e_1_2_19_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.944"},{"key":"e_1_2_19_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.10.009"},{"key":"e_1_2_19_137_1","article-title":"#159 ICON8B: GCIG phase III randomised trial comparing weekly dose\u2010dense chemotherapy\u2009+\u2009bevacizumab to three\u2010weekly chemotherapy+ bevacizumab in first\u2010line high\u2010risk stage III\u2010IV epithelial ovarian cancer treatment: primary progression\u2010free survival analysis","volume":"33","author":"Clamp A","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"e_1_2_19_138_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103799"},{"key":"e_1_2_19_139_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104390"},{"key":"e_1_2_19_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00086-8"},{"key":"e_1_2_19_141_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01009"},{"key":"e_1_2_19_142_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708618"},{"key":"e_1_2_19_143_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00605"},{"key":"e_1_2_19_144_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.5510"},{"key":"e_1_2_19_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.015"},{"key":"e_1_2_19_146_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.5508"},{"key":"e_1_2_19_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.02.020"},{"key":"e_1_2_19_148_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001640"},{"key":"e_1_2_19_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.11.520"},{"key":"e_1_2_19_150_1","article-title":"Maintenance chemotherapy for ovarian cancer","volume":"6","author":"Mei L","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_19_151_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810858"},{"key":"e_1_2_19_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00531-3"},{"key":"e_1_2_19_153_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01549"},{"key":"e_1_2_19_154_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910962"},{"key":"e_1_2_19_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2241"},{"key":"e_1_2_19_156_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.2283"},{"key":"e_1_2_19_157_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy181"},{"key":"e_1_2_19_158_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01003"},{"key":"e_1_2_19_159_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1909707"},{"key":"e_1_2_19_160_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911361"},{"key":"e_1_2_19_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.05.005"},{"key":"e_1_2_19_162_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA5506"},{"key":"e_1_2_19_163_1","article-title":"Durvalumab (D)\u2009+\u2009carboplatin\/paclitaxel (CP)\u2009+\u2009bevacizumab (B) followed by D, B\u2009+\u2009olaparib (O) maintenance (mtx) for newly diagnosed advanced ovarian cancer (AOC) without a tumour BRCA1\/BRCA2 mutation (non\u2010tBRCAm): updated results from DUO\u2010O","volume":"9","author":"Trillsch F","year":"2024","journal-title":"Ann Oncol"},{"key":"e_1_2_19_164_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105535"},{"key":"e_1_2_19_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70228-1"},{"key":"e_1_2_19_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30469-2"},{"key":"e_1_2_19_167_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611310"},{"key":"e_1_2_19_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32440-6"},{"key":"e_1_2_19_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.06.025"},{"key":"e_1_2_19_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2269"},{"key":"e_1_2_19_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2003.08.036"},{"key":"e_1_2_19_172_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200206000-00011"},{"key":"e_1_2_19_173_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21845"},{"key":"e_1_2_19_174_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103294"},{"key":"e_1_2_19_175_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902626"},{"key":"e_1_2_19_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00006-1"},{"key":"e_1_2_19_177_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02981-0"},{"key":"e_1_2_19_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61268-8"},{"key":"e_1_2_19_179_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01182"},{"key":"e_1_2_19_180_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.3.389"},{"key":"e_1_2_19_181_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31821bb8aa"},{"key":"e_1_2_19_182_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-000308"},{"key":"e_1_2_19_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13718-X"},{"key":"e_1_2_19_184_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.0913"},{"key":"e_1_2_19_185_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2006.03.012"},{"key":"e_1_2_19_186_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.307"},{"key":"e_1_2_19_187_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.0505"},{"key":"e_1_2_19_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30142-X"},{"key":"e_1_2_19_189_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30637-9"},{"key":"e_1_2_19_190_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.4489"},{"key":"e_1_2_19_191_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.1408"},{"key":"e_1_2_19_192_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.6005"},{"key":"e_1_2_19_193_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.6258"},{"key":"e_1_2_19_194_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1048"},{"key":"e_1_2_19_195_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02059"},{"key":"e_1_2_19_196_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA5500"},{"key":"e_1_2_19_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2271"},{"key":"e_1_2_19_198_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.5945"},{"key":"e_1_2_19_199_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0582"},{"key":"e_1_2_19_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31774-X"},{"key":"e_1_2_19_201_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1285478"},{"key":"e_1_2_19_202_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30736"},{"key":"e_1_2_19_203_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.01.037"},{"key":"e_1_2_19_204_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.02.017"},{"key":"e_1_2_19_205_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01900"},{"key":"e_1_2_19_206_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309169"},{"key":"e_1_2_19_207_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02005"},{"key":"e_1_2_19_208_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.776"},{"key":"e_1_2_19_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.12.020"},{"key":"e_1_2_19_210_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30029-4"},{"key":"e_1_2_19_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.08.022"},{"key":"e_1_2_19_212_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.646"},{"key":"e_1_2_19_213_1","unstructured":"LeathCA ScambiaG ValenciaRV et\u00a0al.Overall survival by number of prior lines of chemotherapy in patients with BRCA\u2010mutated platinum\u2010sensitive relapsed ovarian cancer receiving olaparib treatment or non\u2010platinum chemotherapy in SOLO3. IGCS 2022 Annual Global Meeting. 2022; New York."},{"key":"e_1_2_19_214_1","unstructured":"Society of Gynecologic Oncologists Clinical Practice C.Summary: Revisions to FDA approvals for PARP inhibitors in the management of ovarian cancer.2022https:\/\/www.sgo.org\/resources\/revisions\u2010to\u2010fda\u2010approvals\u2010for\u2010parp\u2010inhibitors\/"},{"key":"e_1_2_19_215_1","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181bf7fb8"},{"key":"e_1_2_19_216_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2764"},{"issue":"9","key":"e_1_2_19_217_1","article-title":"Cancer: a disease of the genome","volume":"67","author":"Collins F","year":"2007","journal-title":"Cancer Res"},{"issue":"19","key":"e_1_2_19_218_1","first-page":"5329","article-title":"BRCA1 promoter region hypermethylation in ovarian carcinoma: a population\u2010based study","volume":"60","author":"Baldwin RL","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_19_219_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00819-1"},{"key":"e_1_2_19_220_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00640-8"},{"key":"e_1_2_19_221_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2024.152411"},{"key":"e_1_2_19_222_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-24-0319"},{"key":"e_1_2_19_223_1","unstructured":"Marathon of Hope CCN.SCCOHT\/SMARCA4 Registry and Biobank.2024https:\/\/www.marathonofhopecancercentres.ca\/our\u2010research\/project\/sccoht\u2010smarca4\u2010registry\u2010and\u2010biobank"},{"key":"e_1_2_19_224_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12429-w"},{"key":"e_1_2_19_225_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102484"},{"key":"e_1_2_19_226_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000227787.24587.d1"},{"key":"e_1_2_19_227_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.03.001"},{"key":"e_1_2_19_228_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.100212"},{"key":"e_1_2_19_229_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0893"},{"key":"e_1_2_19_230_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.11.013"},{"key":"e_1_2_19_231_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.01.022"},{"key":"e_1_2_19_232_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.02.037"},{"key":"e_1_2_19_233_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.06.011"},{"key":"e_1_2_19_234_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.07.127"},{"key":"e_1_2_19_235_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.0632"},{"key":"e_1_2_19_236_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.06.466"},{"key":"e_1_2_19_237_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30090592"},{"key":"e_1_2_19_238_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70572-7"},{"key":"e_1_2_19_239_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01164"},{"key":"e_1_2_19_240_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz394.058"},{"key":"e_1_2_19_241_1","article-title":"GOG\u20103097\/ENGOT\u2010ov81\/GTG\u2010UK\/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer","author":"Grisham R","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"e_1_2_19_242_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2024.06.008"},{"key":"e_1_2_19_243_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004610"},{"key":"e_1_2_19_244_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.3936"},{"key":"e_1_2_19_245_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<278::AID-CNCR14>3.0.CO;2-T"},{"key":"e_1_2_19_246_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31821bec6b"},{"key":"e_1_2_19_247_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.07.019"},{"key":"e_1_2_19_248_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.10.2658"},{"key":"e_1_2_19_249_1","first-page":"477","volume-title":"Gynecologic Oncology","author":"Berek JS","year":"2021"},{"key":"e_1_2_19_250_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.1005"},{"key":"e_1_2_19_251_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.019"},{"key":"e_1_2_19_252_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.01049.x"},{"key":"e_1_2_19_253_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.01.011"},{"key":"e_1_2_19_254_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5304"},{"key":"e_1_2_19_255_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2024.09.002"},{"key":"e_1_2_19_256_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28421"},{"key":"e_1_2_19_257_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.4574"},{"key":"e_1_2_19_258_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.03.573"},{"key":"e_1_2_19_259_1","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12720"},{"key":"e_1_2_19_260_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.5524"},{"key":"e_1_2_19_261_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909213211204"},{"key":"e_1_2_19_262_1","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181a702d1"},{"key":"e_1_2_19_263_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29532"},{"key":"e_1_2_19_264_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.196"},{"key":"e_1_2_19_265_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.7882"},{"key":"e_1_2_19_266_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.4.701"},{"key":"e_1_2_19_267_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.11.1950"},{"key":"e_1_2_19_268_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.4.715"},{"key":"e_1_2_19_269_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1994.1050"},{"key":"e_1_2_19_270_1","unstructured":"SessaC CalaminusG PlanchampF et\u00a0al.Non\u2010epithelial ovarian cancers in adolescents and young adults. Pocket Guidelines ESGO.2019https:\/\/www.esgo.org\/media\/2019\/12\/Guidelines\u2010Young\u2010Adults\u20102019\u2010ovarian.pdf"},{"key":"e_1_2_19_271_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30091-7"},{"key":"e_1_2_19_272_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.10.009"},{"issue":"4","key":"e_1_2_19_273_1","first-page":"262","article-title":"Laparotomy for post chemotherapy residue in ovarian germ cell tumors","volume":"52","author":"Mathew GK","year":"2006","journal-title":"J Postgrad Med"},{"key":"e_1_2_19_274_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.620"},{"key":"e_1_2_19_275_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.00969.x"},{"key":"e_1_2_19_276_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi817"},{"key":"e_1_2_19_277_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.07.044"},{"key":"e_1_2_19_278_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.05.025"},{"key":"e_1_2_19_279_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy001"},{"key":"e_1_2_19_280_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-007-0693-7"},{"key":"e_1_2_19_281_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1997.4625"},{"key":"e_1_2_19_282_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1738::AID-CNCR21>3.0.CO;2-4"},{"key":"e_1_2_19_283_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12614"},{"key":"e_1_2_19_284_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2013.10.001"},{"key":"e_1_2_19_285_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1748"},{"key":"e_1_2_19_286_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.06.003"}],"container-title":["International Journal of Gynecology &amp; Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijgo.70282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:50:05Z","timestamp":1757591405000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/ijgo.70282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":285,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1002\/ijgo.70282"],"URL":"https:\/\/doi.org\/10.1002\/ijgo.70282","archive":["Portico"],"relation":{},"ISSN":["0020-7292","1879-3479"],"issn-type":[{"value":"0020-7292","type":"print"},{"value":"1879-3479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2024-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}